EFSA ei ole löytänyt ruisleivästä mitään muuta terveellistä kuin kuidun (näyttö ei riitä) http://www.efsa.europa.eu/en/efsajournal/pub/2258
Uskotko, että ruisleipä on terveellistä? Perustele kantasi.
Summary
Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked to provide a scientific opinion on a list of health claims pursuant to Article 13 of Regulation (EC) No 1924/2006. This opinion addresses the scientific substantiation of health claims in relation to rye fibre and changes in bowel function, reduction of post-prandial glycaemic responses and maintenance of normal blood LDL-cholesterol concentrations. The scientific substantiation is based on the information provided by the Member States in the consolidated list of Article 13 health claims and references that EFSA has received from Member States or directly from stakeholders.
The food constituent that is the subject of the health claims is rye fibre. The Panel considers that rye fibre is sufficiently characterised in relation to the claimed effects.
Changes in bowel function
The claimed effect is “gut health”. The target population is assumed to be the general population. In the context of the clarifications provided by Member States, the Panel assumes that the claimed effect refers to changes in bowel function. The Panel considers that changes in bowel function such as reduced transit time, more frequent bowel movements, increased faecal bulk, or softer stools may be a beneficial physiological effect, provided these changes do not result in diarrhoea.
In weighing the evidence, the Panel took into account that the results of all four human intervention studies considered showed an effect of rye fibre on various outcome measures related to bowel function. The Panel also notes the known mechanism by which rye fibre exerts the claimed effect.
On the basis of the data presented, the Panel concludes that a cause and effect relationship has been established between the consumption of rye fibre and changes in bowel function. (hyvä vai paha?)
The Panel considers that in order to bear the claim a food should be at least “high in fibre” as per Annex to Regulation (EC) No 1924/2006. The target population is the general population.
Reduction of post-prandial glycaemic responses
The claimed effect is “carbohydrate metabolism and insulin sensitivity”. The target population is assumed to be individuals who wish to reduce their post-prandial glycaemic responses. In the context of the proposed wordings, the Panel assumes that the claimed effect relates to the reduction of post-prandial glycaemic responses. The Panel considers that reduction of post-prandial glycaemic responses (as long as post prandial insulinaemic responses are not disproportionally increased) may be a beneficial physiological effect.
In weighing the evidence, the Panel took into account that the three human intervention studies provided from which conclusions could be drawn for the scientific substantiation of the claim, did not show an effect of rye fibre on post prandial glycaemic responses.
On the basis of the data presented, the Panel concludes that a cause and effect relationship has not been established between the consumption of rye fibre and reduction of post-prandial glycaemic responses.
Maintenance of normal blood LDL-cholesterol concentrations
The claimed effect is “cardiovascular system”. The target population is assumed to be the general population. In the context of the proposed wordings and clarifications provided by Member States, the Panel assumes that the claimed effect refers to the maintenance of normal blood LDL-cholesterol concentrations. The Panel considers that maintenance of normal blood LDL-cholesterol concentrations is a beneficial physiological effect.
In weighing the evidence, the Panel took into account that the only human intervention study provided from which conclusions could be drawn for the scientific substantiation of the claim did not show an effect of rye fibre on blood LDL-cholesterol concentrations.
On the basis of the data presented, the Panel concludes that a cause and effect relationship has not been established between the consumption of rye fibre and maintenance of normal blood LDL-cholesterol concentrations.
Uskotko, että ruisleipä on terveellistä? Perustele kantasi.
Summary
Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked to provide a scientific opinion on a list of health claims pursuant to Article 13 of Regulation (EC) No 1924/2006. This opinion addresses the scientific substantiation of health claims in relation to rye fibre and changes in bowel function, reduction of post-prandial glycaemic responses and maintenance of normal blood LDL-cholesterol concentrations. The scientific substantiation is based on the information provided by the Member States in the consolidated list of Article 13 health claims and references that EFSA has received from Member States or directly from stakeholders.
The food constituent that is the subject of the health claims is rye fibre. The Panel considers that rye fibre is sufficiently characterised in relation to the claimed effects.
Changes in bowel function
The claimed effect is “gut health”. The target population is assumed to be the general population. In the context of the clarifications provided by Member States, the Panel assumes that the claimed effect refers to changes in bowel function. The Panel considers that changes in bowel function such as reduced transit time, more frequent bowel movements, increased faecal bulk, or softer stools may be a beneficial physiological effect, provided these changes do not result in diarrhoea.
In weighing the evidence, the Panel took into account that the results of all four human intervention studies considered showed an effect of rye fibre on various outcome measures related to bowel function. The Panel also notes the known mechanism by which rye fibre exerts the claimed effect.
On the basis of the data presented, the Panel concludes that a cause and effect relationship has been established between the consumption of rye fibre and changes in bowel function. (hyvä vai paha?)
The Panel considers that in order to bear the claim a food should be at least “high in fibre” as per Annex to Regulation (EC) No 1924/2006. The target population is the general population.
Reduction of post-prandial glycaemic responses
The claimed effect is “carbohydrate metabolism and insulin sensitivity”. The target population is assumed to be individuals who wish to reduce their post-prandial glycaemic responses. In the context of the proposed wordings, the Panel assumes that the claimed effect relates to the reduction of post-prandial glycaemic responses. The Panel considers that reduction of post-prandial glycaemic responses (as long as post prandial insulinaemic responses are not disproportionally increased) may be a beneficial physiological effect.
In weighing the evidence, the Panel took into account that the three human intervention studies provided from which conclusions could be drawn for the scientific substantiation of the claim, did not show an effect of rye fibre on post prandial glycaemic responses.
On the basis of the data presented, the Panel concludes that a cause and effect relationship has not been established between the consumption of rye fibre and reduction of post-prandial glycaemic responses.
Maintenance of normal blood LDL-cholesterol concentrations
The claimed effect is “cardiovascular system”. The target population is assumed to be the general population. In the context of the proposed wordings and clarifications provided by Member States, the Panel assumes that the claimed effect refers to the maintenance of normal blood LDL-cholesterol concentrations. The Panel considers that maintenance of normal blood LDL-cholesterol concentrations is a beneficial physiological effect.
In weighing the evidence, the Panel took into account that the only human intervention study provided from which conclusions could be drawn for the scientific substantiation of the claim did not show an effect of rye fibre on blood LDL-cholesterol concentrations.
On the basis of the data presented, the Panel concludes that a cause and effect relationship has not been established between the consumption of rye fibre and maintenance of normal blood LDL-cholesterol concentrations.
Viimeksi muokattu: